{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:06:04Z","timestamp":1790525164464,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.revmed.2016.12.024","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T20:46:45Z","timestamp":1487191605000},"page":"539-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["M\u00e9susage et d\u00e9pendance aux opio\u00efdes de prescription\u00a0: pr\u00e9vention, rep\u00e9rage et prise en charge"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-3635","authenticated-orcid":false,"given":"B.","family":"Rolland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bouhassira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Auriacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Polomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bendimerad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vergne-Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dematteis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.12.024_bib0260","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Prescription Drug Misuse and Abuse. http:\/\/www.samhsa.gov\/prescription-drug-misuse-abuse (consult\u00e9 le 26\/09\/16)."},{"key":"10.1016\/j.revmed.2016.12.024_bib0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.revmed.2016.12.024_bib0270","series-title":"Biological research on addiction: comprehensive addictive behaviors disorders","year":"2013"},{"key":"10.1016\/j.revmed.2016.12.024_bib0275","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5\u00a0criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.revmed.2016.12.024_bib0280","first-page":"1","article-title":"The problems of long-term treatment with benzodiazepines and related substances","volume":"112","author":"Janhsen","year":"2015","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"10.1016\/j.revmed.2016.12.024_bib0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.02.030","article-title":"Long-term outcomes from the national drug abuse treatment clinical trials network prescription opioid addiction treatment study","volume":"150","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2016.12.024_bib0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugalcdep.2010.11.007","article-title":"Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997\u20132007","volume":"115","author":"Green","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2016.12.024_bib0295","doi-asserted-by":"crossref","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: a review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.revmed.2016.12.024_bib0300","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/j.1360-0443.2012.03975.x","article-title":"Correlates of benzodiazepine dependence in the Netherlands study of depression and anxiety","volume":"107","author":"Manthey","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.revmed.2016.12.024_bib0305","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0310","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.revmed.2016.12.024_bib0315","series-title":"Dark Paradise: a history of opiate addiction in America","author":"Courtwright","year":"2009"},{"key":"10.1016\/j.revmed.2016.12.024_bib0320","series-title":"Strat\u00e9gies th\u00e9rapeutiques pour les personnes d\u00e9pendantes des opiac\u00e9s\u00a0: place des traitements de substitution","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2004"},{"key":"10.1016\/j.revmed.2016.12.024_bib0325","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1521-0391.2013.12038.x","article-title":"Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence","volume":"22","author":"Barth","year":"2013","journal-title":"Am J Addict"},{"key":"10.1016\/j.revmed.2016.12.024_bib0330","series-title":"Opioid consumption maps: morphine, mg\/capita","author":"Pain Policy Studies Group","year":"2014"},{"key":"10.1016\/j.revmed.2016.12.024_bib0335","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.36076\/ppj.2014\/17\/E119","article-title":"Assessment of the trends in medical use and misuse of opioid analgesics from 2004\u00a0to 2011","volume":"17","author":"Atluri","year":"2014","journal-title":"Pain Physician"},{"key":"10.1016\/j.revmed.2016.12.024_bib0340","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00228-014-1783-x","article-title":"Detection of signals of abuse and dependence applying disproportionality analysis","volume":"71","author":"Pauly","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2016.12.024_bib0345","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/11316590-000000000-00000","article-title":"Evaluation of abuse and dependence on drugs used for self-medication: a pharmaco-epidemiological pilot study based on community pharmacies in France","volume":"32","author":"Orriols","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.revmed.2016.12.024_bib0350","doi-asserted-by":"crossref","first-page":"e76499","DOI":"10.1371\/journal.pone.0076499","article-title":"Misuse and dependence on non-prescription codeine analgesics or sedative H1\u00a0antihistamines by adults: a cross-sectional investigation in France","volume":"8","author":"Roussin","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.revmed.2016.12.024_bib0355","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.lpm.2016.02.014","article-title":"Utilisation des opio\u00efdes forts dans la douleur chronique non canc\u00e9reuse chez l\u2019adulte. Recommandations fran\u00e7aises de bonne pratique clinique par consensus formalis\u00e9 (SFETD)","volume":"45","author":"Moisset","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0360","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0365","series-title":"D\u00e9c\u00e8s en relation avec l\u2019abus de m\u00e9dicaments et de substances (Drames)\u00a0: r\u00e9sultats de l\u2019enqu\u00eate 2012","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2012"},{"key":"10.1016\/j.revmed.2016.12.024_bib0370","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2015.15020262","article-title":"Prescription opioid misuse, abuse and treatment in the United States: an update","volume":"173","author":"Brady","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.revmed.2016.12.024_bib0375","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.mjt.0000212894.35705.90","article-title":"Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports","volume":"13","author":"Miller","year":"2006","journal-title":"Am J Ther"},{"key":"10.1016\/j.revmed.2016.12.024_bib0380","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.mcna.2006.10.003","article-title":"Opioid tolerance and hyperalgesia","volume":"91","author":"Chang","year":"2007","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.revmed.2016.12.024_bib0385","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/7854_2014_351","article-title":"Endogenous analgesia, dependence and latent pain sensitization","volume":"20","author":"Taylor","year":"2014","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.revmed.2016.12.024_bib0390","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50\u00a0years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.revmed.2016.12.024_bib0395","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.addbeh.2014.05.025","article-title":"Sleep disturbances and pain among individuals with prescription opioid dependence","volume":"39","author":"Hartwell","year":"2014","journal-title":"Addict Behav"},{"key":"10.1016\/j.revmed.2016.12.024_bib0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ajad.12188","article-title":"Health-related quality of life among prescription opioid-dependent patients: results from a multi-site study","volume":"24","author":"Griffin","year":"2015","journal-title":"Am J Addict"},{"key":"10.1016\/j.revmed.2016.12.024_bib0405","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1017\/S0033291711002145","article-title":"Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on alcohol and related conditions","volume":"42","author":"Martins","year":"2012","journal-title":"Psychol Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0410","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2014.02.701","article-title":"Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially insured individuals","volume":"138","author":"Cochran","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2016.12.024_bib0415","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.genhosppsych.2015.05.004","article-title":"Associations of borderline personality with pain, problems with medications and suicidality in a community sample of chronic non-cancer pain patients prescribed opioids for pain","volume":"37","author":"Campbell","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.revmed.2016.12.024_bib0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2012.06.032","article-title":"Risk for prescription opioid misuse among patients with a history of substance use disorder","volume":"127","author":"Morasco","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2016.12.024_bib0425","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00002018-200730030-00007","article-title":"French network of centers for evaluation and information pharmacodependence (CEIP). Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey","volume":"30","author":"Boeuf","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.revmed.2016.12.024_bib0430","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/070674370805300804","article-title":"Assessment and management of chronic pain in individuals seeking treatment for opioid dependence disorder","volume":"53","author":"Clark","year":"2008","journal-title":"Can J Psychiatry"},{"issue":"4","key":"10.1016\/j.revmed.2016.12.024_bib0435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/AJP.0000000000000268","article-title":"Primary care physicians\u2019 knowledge and attitudes regarding prescription opioid abuse and diversion","volume":"32","author":"Hwang","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.revmed.2016.12.024_bib0440","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2: guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.revmed.2016.12.024_bib0445","first-page":"571","article-title":"Use of morphine in non-malignant joint pain: the Limoges recommendations. The French Society for Rheumatology","volume":"66","author":"Perrot","year":"1999","journal-title":"Rev Rhum"},{"key":"10.1016\/j.revmed.2016.12.024_bib0450","first-page":"259","article-title":"Les opio\u00efdes forts dans les douleurs ost\u00e9o-articulaires non canc\u00e9reuses\u00a0: revue de la litt\u00e9rature et recommandations pour la pratique clinique\u00a0: \u00ab\u00a0Les recommandations de Limoges 2010\u00a0\u00bb","volume":"13","author":"Vergne-Salle","year":"2012","journal-title":"Douleurs"},{"key":"10.1016\/j.revmed.2016.12.024_bib0455","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0460","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jsat.2008.02.001","article-title":"Prescription opioid misuse index: a brief questionnaire to assess misuse","volume":"35","author":"Knisely","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.revmed.2016.12.024_bib0465","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpain.2007.11.014","article-title":"Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R)","volume":"9","author":"Butler","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.revmed.2016.12.024_bib0470","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/ADM.0b013e31818e41da","article-title":"Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R)","volume":"3","author":"Butler","year":"2009","journal-title":"J Addict Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0475","first-page":"S1","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I: evidence assessment","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.revmed.2016.12.024_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.05.033","article-title":"The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review","volume":"119","author":"Dunn","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2016.12.024_bib0485","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.revmed.2016.12.024_bib0490","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamapsychiatry.2013.2216","article-title":"A randomized and double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers","volume":"70","author":"Sigmon","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.revmed.2016.12.024_bib0495","first-page":"1947","article-title":"Primary care-based buprenorphine taper vs. maintenance therapy for prescription opioid dependence: a randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Intern"},{"key":"10.1016\/j.revmed.2016.12.024_bib0500","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11606-011-1962-8","article-title":"Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care","volume":"27","author":"Schackman","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0505","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-160-1-201401070-00732","article-title":"Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain","volume":"160","author":"Nuckols","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2016.12.024_bib0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00207411.2014.1003734","article-title":"The system of medical treatment for addiction in France","volume":"43","author":"Cottencin","year":"2014","journal-title":"Int J Ment Health"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317300218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317300218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:38:24Z","timestamp":1759336704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866317300218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0248866317300218"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.12.024","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9susage et d\u00e9pendance aux opio\u00efdes de prescription\u00a0: pr\u00e9vention, rep\u00e9rage et prise en charge","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}